scholarly article | Q13442814 |
P2093 | author name string | Peter J Barnes | |
P2860 | cites work | The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. | Q53951321 |
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease | Q58057647 | ||
Chronic Obstructive Pulmonary Disease Is Associated with Lung Cancer Mortality in a Prospective Study of Never Smokers | Q58260316 | ||
From COPD to chronic systemic inflammatory syndrome? | Q58877168 | ||
Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease | Q81901203 | ||
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease | Q29618681 | ||
Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study | Q33301961 | ||
The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial | Q34394365 | ||
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history | Q34604212 | ||
Cognitive decline among patients with chronic obstructive pulmonary disease | Q34979736 | ||
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis | Q35536791 | ||
Osteoporosis in chronic obstructive pulmonary disease patients | Q37095795 | ||
COPD as a disease of accelerated lung aging | Q37366212 | ||
Systemic manifestations and comorbidities of COPD. | Q37465879 | ||
Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study. | Q39965893 | ||
Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease | Q43281145 | ||
Vascular dysfunction in chronic obstructive pulmonary disease. | Q45960606 | ||
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. | Q46562371 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic obstructive pulmonary disease | Q199804 |
P304 | page(s) | e1000220 | |
P577 | publication date | 2010-03-16 | |
P1433 | published in | PLOS MEDICINE | Q1686921 |
P1476 | title | Chronic obstructive pulmonary disease: effects beyond the lungs. | |
P478 | volume | 7 |
Q36817922 | A comparison of cognitive functions in non-hypoxemic chronic obstructive pulmonary disease (COPD) patients and age-matched healthy volunteers using mini-mental state examination questionnaire and event-related potential, P300 analysis |
Q28394423 | Air Pollution and Lung Function Loss: The Importance of Metabolic Syndrome |
Q47728819 | An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations? |
Q90705495 | Anti-Inflammatory Effects of Licania macrocarpa Cuatrec Methanol Extract Target Src- and TAK1-Mediated Pathways |
Q36137286 | Assessment of cognitive impairment in long-term oxygen therapy-dependent COPD patients. |
Q36345889 | Association Between Emphysema Score, Six-Minute Walk and Cardiopulmonary Exercise Tests in COPD. |
Q23918414 | Biomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV1 decline |
Q26786812 | COPD and its comorbidities: Impact, measurement and mechanisms |
Q60301064 | COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure |
Q89219136 | Chronic obstructive pulmonary disease |
Q55381292 | Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes. |
Q34228984 | Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat |
Q36308003 | Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study). |
Q50698868 | Diabetes mellitus among outpatients with COPD attending a university hospital. |
Q58694600 | Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD |
Q46738415 | Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity |
Q64095387 | Disrupted resting-state spontaneous neural activity in stable COPD |
Q51760032 | Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging. |
Q39440580 | Effect of Hypoxic Injury in Mood Disorder |
Q88536449 | Evaluation for airway obstruction in adult patients with stable ischemic heart disease |
Q36929346 | Evaluation of C-Reactive Protein in Patients with Chronic Obstructive Pulmonary Disease |
Q28383778 | Gene promoter methylation is associated with lung function in the elderly: the Normative Aging Study |
Q28730169 | Grey and white matter abnormalities in chronic obstructive pulmonary disease: a case-control study |
Q34390635 | Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two? |
Q36677305 | High-sensitivity cardiac troponin T levels are increased in stable COPD. |
Q86984320 | IL-21 is increased in peripheral blood of emphysema mice and promotes Th1/Tc1 cell generation in vitro |
Q34126289 | Identification of Novel Therapeutic Targets in COPD. |
Q34126693 | Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke |
Q48541057 | Impact of pharmaceutical care on health outcomes in patients with COPD. |
Q33592661 | Increased risk and related factors of depression among patients with COPD: a population-based cohort study. |
Q90636017 | Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk |
Q23909997 | Inflammatory biomarkers predict airflow obstruction after exposure to World Trade Center dust |
Q37964807 | Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice |
Q35204219 | Lung disease as a determinant of cognitive decline and dementia |
Q27005858 | Managing comorbidities in COPD |
Q62731134 | Metabolic Syndrome and Air Pollution: A Narrative Review of Their Cardiopulmonary Effects |
Q92068171 | Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs |
Q37102124 | Metabolic syndrome and chronic obstructive pulmonary disease |
Q23910631 | Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study |
Q33554524 | Metabolic syndrome in patients with chronic obstructive pulmonary disease: frequency and relationship with systemic inflammation |
Q38821943 | MicroRNA expression profiling defines the impact of electronic cigarettes on human airway epithelial cells. |
Q62111191 | Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease |
Q21146673 | Network medicine analysis of COPD multimorbidities |
Q35009154 | Neural mechanisms underlying breathing complexity |
Q38131512 | New anti-inflammatory targets for chronic obstructive pulmonary disease. |
Q64118155 | New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease |
Q39020385 | Pathogenesis of COPD and Asthma. |
Q64067266 | Prior cigarette smoke exposure does not affect acute post-stroke outcomes in mice |
Q64913353 | Reduced Lung Function in Midlife and Cognitive Impairment in the Elderly. |
Q40927157 | Reduced cortical thickness, surface area in patients with chronic obstructive pulmonary disease: a surface-based morphometry and neuropsychological study |
Q48420302 | Reduced regional gray matter volume in patients with chronic obstructive pulmonary disease: a voxel-based morphometry study |
Q41665936 | Relationship between pulmonary function and elevated glycated hemoglobin levels in health checkups: A cross-sectional observational study in Japanese participants |
Q53305583 | Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes. |
Q38306695 | Safety of inhaled corticosteroids for treating chronic obstructive pulmonary disease. |
Q35667313 | Self Reported Childhood Difficulties, Adult Multimorbidity and Allostatic Load. A Cross-Sectional Analysis of the Norwegian HUNT Study |
Q37006598 | The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease |
Q60921746 | The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review |
Q33719462 | The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats |
Q33832184 | Uncovering Metabolic Syndrome among Chronic Obstructive Pulmonary Disease Patients in a Tertiary Care Hospital, India |
Q37896652 | Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms |
Q60050074 | Visual rating assessment of cerebral atrophy and its relationship with cognitive function in chronic obstructive pulmonary disease |
Q58840477 | What the Journal Would Like to Publish on Chronic Obstructive Pulmonary Disease |
Q36265683 | Which patients with advanced respiratory disease die in hospital? A 14-year population-based study of trends and associated factors |
Q33810474 | White matter lesions characterise brain involvement in moderate to severe chronic obstructive pulmonary disease, but cerebral atrophy does not |
Q84766067 | [Pulmonary diseases in the elderly] |
Q85648640 | [Stress and optimal ageing] |
Search more.